ReviewRheumatology international2023
Autoimmune rheumatic diseases associated with granulomatous mastitis.
Review in Rheumatology international, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 18 citations in OpenAlex.
- Granulomatous mastitis, erythema nodosum, and arthritis syndrome: a narrative review.Frontiers in immunology · 2025Pooled it
- >Efficacy of disease-modifying antirheumatic drugs in the treatment of granulomatous mastitis: a systematic review.Rheumatology international · 2024Pooled it
- Beyond the breast: systemic autoimmune and malignancy associations in idiopathic granulomatous mastitis.International journal of women's dermatology · 2026Article
- A rare case of mastitis involving granulomatosis with polyangiitis after immune checkpoint inhibitor therapy.International cancer conference journal · 2026Article
- Is granulomatous mastitis a rheumatologic disease? The emerging role of rheumatologists in disease management.Rheumatology international · 2025Review
- Treatment of idiopathic granulomatous mastitis: a retrospective case series.Rheumatology international · 2025Article
- Granulomatous Mastitis-Related Large Skin Defect in a Patient With Ulcerative Colitis on Mesalazine Therapy.Cureus · 2025Article
- Is Idiopathic Granulomatous Mastitis a Subgroup of Systemic Lupus Erythematosus? A Preliminary Study.Journal of clinical medicine · 2024Article
- The role of tissue IgG4 levels in steroid therapy in patients with idiopathic granulomatous mastitis.Clinical and experimental medicine · 2024Article
- Article
- Article
- Mendelian randomization suggests causal correlations between inflammatory cytokines and immune cells with mastitis.Frontiers in immunology · 2024Article
- Idiopathic granulomatous mastitis: clinical, histopathological, and radiological characteristics and management approaches.Rheumatology international · 2023Article
- Ozone therapy as a novel complementary therapeutic approach in refractory idiopathic granulomatous mastitis.Frontiers in medicine · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Granulomatous mastitis (GM) is a benign, inflammatory condition of the breast that mainly affects women of reproductive age. Although its pathogenesis remains unknown, previous studies revealed an association between autoimmune rheumatic diseases (ARDs) and GM in a subset of patients implicating immune-mediated mechanisms. The aim of this narrative review was to identify and describe the ARDs associated with GM to shed further light on disease pathogenesis. We conducted a comprehensive literature search of patients presenting with GM and coexisting ARDs using electronic databases. An association between GM and various ARDs has been reported, including sarcoidosis, systematic lupus erythematosus, granulomatosis with polyangiitis, psoriasis/psoriatic arthritis, familial Mediterranean fever, ankylosing spondylitis, Sjogren's syndrome, rheumatoid arthritis, and erythema nodosum, with the most common being granulomatous mastitis-erythema nodosum-arthritis syndrome (GMENA), granulomatosis with polyangiitis (Wegener's) and sarcoidosis. In addition, clinical characteristics, diagnostic and therapeutic approaches were recorded. Further research is warranted to better understand the association between GM and ARDs and raise awareness amongst rheumatologists.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.